- Home
- ISPC vs SNSE Comparison
ISPC vs SNSE Comparison
Compare ISPC & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- SNSE
- Stock Information
- Founded
- ISPC 2009
- SNSE 2005
- Country
- ISPC United States
- SNSE United States
- Employees
- ISPC N/A
- SNSE N/A
- Industry
- ISPC Precision Instruments
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- ISPC Health Care
- SNSE Health Care
- Exchange
- ISPC Nasdaq
- SNSE Nasdaq
- Market Cap
- ISPC 13.9M
- SNSE 11.2M
- IPO Year
- ISPC 2021
- SNSE 2021
- Fundamental
- Price
- ISPC $1.55
- SNSE $9.30
- Analyst Decision
- ISPC
- SNSE Strong Buy
- Analyst Count
- ISPC 0
- SNSE 4
- Target Price
- ISPC N/A
- SNSE $72.50
- AVG Volume (30 Days)
- ISPC 20.5M
- SNSE 6.0K
- Earning Date
- ISPC 11-06-2025
- SNSE 11-13-2025
- Dividend Yield
- ISPC N/A
- SNSE N/A
- EPS Growth
- ISPC N/A
- SNSE N/A
- EPS
- ISPC N/A
- SNSE N/A
- Revenue
- ISPC $5,908,088.00
- SNSE N/A
- Revenue This Year
- ISPC $35.93
- SNSE N/A
- Revenue Next Year
- ISPC N/A
- SNSE N/A
- P/E Ratio
- ISPC N/A
- SNSE N/A
- Revenue Growth
- ISPC N/A
- SNSE N/A
- 52 Week Low
- ISPC $0.64
- SNSE $5.00
- 52 Week High
- ISPC $8.30
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- ISPC 56.57
- SNSE 59.72
- Support Level
- ISPC $1.47
- SNSE $8.41
- Resistance Level
- ISPC $2.58
- SNSE $9.49
- Average True Range (ATR)
- ISPC 0.47
- SNSE 0.58
- MACD
- ISPC 0.08
- SNSE 0.08
- Stochastic Oscillator
- ISPC 35.83
- SNSE 88.30
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).